Ms4a1 Antibody

1. Our findings indicate that anti-CD20-IFNalpha eradicates B-cell lymphoma by employing tumor cells as antigen-presenting cells to reactivate tumor-infiltrating CD8(+) T cells and synergizing with anti-PD-L1 treatment PMID: 28533311
2. Galectin-1 has a role in driving lymphoma CD20 immunotherapy resistance in a mouse model PMID: 26888257
3. Results indicate that an antigen-specific B cell response towards intracellular pathogens can be generated during anti-CD20 depletion therapy. PMID: 26261496
4. this study demonstrates a role for CD20 in B cell activation and T-dependent humoral immunity. PMID: 23966626
5. CD20 is required for store-operated calcium entry in C2C12 myoblasts. PMID: 22982241
6. immunization of mice with the CD20 extracellular domain-6 using Freund's or QS-21 adjuvants was shown to exert significant biological effects in vivo with the pronounced depletion of splenic B cells. PMID: 20189250
7. type I CD20 antibody cytotoxicity critically depends on Fc receptor ITAM signaling PMID: 20354182
8. CD20 deficiency in humans results in impaired T cell-independent antibody responses. PMID: 20038800
9. review of structure, function, tissue and cell distribution PMID: 12144126
10. Anti-CD20 antibodies rapidly depleted the vast majority of circulating and tissue B cells in an isotype-restricted manner dependent on effector cell Fc receptor expression. PMID: 15210744
11. expression in bacterial cells; isolation and biophysical and structural studies PMID: 16285718
12. In mice treated with anti-CD20 mAb, development of arthritis was significantly reduced in comparison to control mAb-treated mice PMID: 18354225
13. involvement of CD20 in calcium influx PMID: 18474602

Show More

Hide All

KEGG: mmu:12482

STRING: 10090.ENSMUSP00000126422

UniGene: Mm.4046